Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;3(3):428-441.
doi: 10.1038/s42255-021-00362-2. Epub 2021 Mar 23.

STK3/STK4 signalling in adipocytes regulates mitophagy and energy expenditure

Affiliations

STK3/STK4 signalling in adipocytes regulates mitophagy and energy expenditure

Yoon Keun Cho et al. Nat Metab. 2021 Mar.

Abstract

Obesity reduces adipocyte mitochondrial function, and expanding adipocyte oxidative capacity is an emerging strategy to improve systemic metabolism. Here, we report that serine/threonine-protein kinase 3 (STK3) and STK4 are key physiological suppressors of mitochondrial capacity in brown, beige and white adipose tissues. Levels of STK3 and STK4, kinases in the Hippo signalling pathway, are greater in white than brown adipose tissues, and levels in brown adipose tissue are suppressed by cold exposure and greatly elevated by surgical denervation. Genetic inactivation of Stk3 and Stk4 increases mitochondrial mass and function, stabilizes uncoupling protein 1 in beige adipose tissue and confers resistance to metabolic dysfunction induced by high-fat diet feeding. Mechanistically, STK3 and STK4 increase adipocyte mitophagy in part by regulating the phosphorylation and dimerization status of the mitophagy receptor BNIP3. STK3 and STK4 expression levels are elevated in human obesity, and pharmacological inhibition improves metabolic profiles in a mouse model of obesity, suggesting STK3 and STK4 as potential targets for treating obesity-related diseases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kusminski, C. M., Bickel, P. E. & Scherer, P. E. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat. Rev. Drug Discov. 15, 639–660 (2016). - DOI - PubMed
    1. Wilson-Fritch, L. et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114, 1281–1289 (2004). - PubMed - PMC - DOI
    1. Hallgren, P., Sjöström, L., Hedlund, H., Lundell, L. & Olbe, L. Influence of age, fat cell weight and obesity on O2 consumption of human adipose tissue. Am. J. Physiol. 256, E467–E474 (1989). - PubMed
    1. Flachs, P., Rossmeisl, M., Kuda, O. & Kopecky, J. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype. Biochim. Biophys. Acta 1831, 986–1003 (2013). - DOI - PubMed
    1. Sidossis, L. & Kajimura, S. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. J. Clin. Invest. 125, 478–486 (2015). - PubMed - PMC - DOI

Publication types

Substances

LinkOut - more resources